ACON ACLARION INC

$2.46

ACLARION INC (ACON) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $1.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.1% since its last earnings release on August 6, 2026.

ACLARION INC Missed Consensus Estimates
Thursday, August 6, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · Before Open
Earnings Whisper
-
vs ($1.05)
Rev est $40K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ACLARION INC

Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.

Sector

Healthcare

Industry

Healthcare Info Services